Dell Faulkingham - Net Worth and Insider Trading
Dell Faulkingham Net Worth
The estimated net worth of Dell Faulkingham is at least $265,829 dollars as of 2024-11-13. Dell Faulkingham is the SVP, CCO of Akebia Therapeutics Inc and owns about 137,025 shares of Akebia Therapeutics Inc (AKBA) stock worth over $265,829. Details can be seen in Dell Faulkingham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dell Faulkingham has not made any transactions after 2021-04-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dell Faulkingham
Dell Faulkingham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dell Faulkingham owns 1 companies in total, including Akebia Therapeutics Inc (AKBA) .
Click here to see the complete history of Dell Faulkingham’s form 4 insider trades.
Insider Ownership Summary of Dell Faulkingham
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2021-04-01 | CCO |
Dell Faulkingham Latest Holdings Summary
Dell Faulkingham currently owns a total of 1 stock. Dell Faulkingham owns 137,025 shares of Akebia Therapeutics Inc (AKBA) as of April 1, 2021, with a value of $265,829.
Latest Holdings of Dell Faulkingham
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2021-04-01 | 137,025 | 1.94 | 265,829 |
Holding Weightings of Dell Faulkingham
Dell Faulkingham Form 4 Trading Tracker
According to the SEC Form 4 filings, Dell Faulkingham has made a total of 2 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 952 shares on April 1, 2021, which brought Dell Faulkingham around $3,237.
Insider Trading History of Dell Faulkingham
- 1
Dell Faulkingham Trading Performance
Dell Faulkingham Ownership Network
Ownership Network List of Dell Faulkingham
Ownership Network Relation of Dell Faulkingham
Dell Faulkingham Owned Company Details
What does Akebia Therapeutics Inc do?
Who are the key executives at Akebia Therapeutics Inc?
Dell Faulkingham is the CCO of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , SVP & General Counsel & Sec. Nicole R. Hadas , and director & CEO & President John P. Butler .
Akebia Therapeutics Inc (AKBA) Insider Trades Summary
Over the past 18 months, Dell Faulkingham made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 149,723 shares made by Michel Dahan , a net sale of 106,103 shares made by Steven Keith Burke , and a net sale of 88,587 shares made by Nicole R. Hadas .
In summary, during the past 3 months, insiders sold 0 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 492,283 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 492,283 shares.
Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akebia Therapeutics Inc Insider Transactions
Dell Faulkingham Mailing Address
Above is the net worth, insider trading, and ownership report for Dell Faulkingham. You might contact Dell Faulkingham via mailing address: C/o Akebia Therapeutics, Inc., 245 First Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
